Artificial Liver Support Systems in Acute Liver Failure and Acute-on-Chronic Liver Failure: Systematic Review and Meta-Analysis

医学 荟萃分析 不利影响 肝性脑病 内科学 肝移植 相对风险 随机对照试验 体外 数据提取 梅德林 重症监护医学 移植 置信区间 肝硬化 法学 政治学
作者
Robert S. Brown,Robert A. Fisher,Ram Subramanian,Adam Griesemer,Milene Fernandes,William H. Thatcher,Kathryn Stiede,Michael Curtis
出处
期刊:Critical care explorations [Wolters Kluwer]
卷期号:7 (1): e1199-e1199 被引量:17
标识
DOI:10.1097/cce.0000000000001199
摘要

OBJECTIVES: To systematically review the safety and efficacy of nonbiological (NBAL) or biological artificial liver support systems (BAL) and whole-organ extracorporeal liver perfusion (W-ECLP) systems, in adults with acute liver failure (ALF) and acute-on-chronic liver failure (ACLF). DATA SOURCES: Eligible NBAL/BAL studies from PubMed/Embase searches were randomized controlled trials (RCTs) in adult patients with ALF/ACLF, greater than or equal to ten patients per group, reporting outcomes related to survival, adverse events, transplantation rate, and hepatic encephalopathy, and published in English from January 2000 to July 2023. Separately, we searched for studies evaluating W-ECLP in adult patients with ALF or ACLF published between January1990 and July 2023. STUDY SELECTION AND DATA EXTRACTION: Two researchers independently screened citations for eligibility and, of eligible studies, retrieved data related to study characteristics, patients and interventions, outcomes definition, and intervention effects. The Cochrane Risk of Bias 2 tool and Joanna Briggs Institute checklists were used to assess individual study risk of bias. Meta-analysis of mortality at 28-30 days post-support system initiation and frequency of at least one serious adverse event (SAE) generated pooled risk ratios (RRs), based on random (mortality) or fixed (SAE) effects models. DATA SYNTHESIS: Of 17 trials evaluating NBAL/BAL systems, 11 reported 28-30 days mortality and five reported frequency of at least one SAE. Overall, NBAL/BAL was not statistically associated with mortality at 28-30 days (RR, 0.85; 95% CI, 0.67-1.07; p = 0.169) or frequency of at least one SAE (RR, 1.15; 95% CI, 0.99-1.33; p = 0.059), compared with standard medical treatment. Subgroup results on ALF patients suggest possible benefit for mortality (RR, 0.67; 95% CI, 0.44-1.03; p = 0.069). From six reports of W-ECLP (12 patients), more than half (58%) of severe patients were bridged to transplantation and survived without transmission of porcine retroviruses. CONCLUSIONS: Despite no significant pooled effects of NBAL/BAL devices, the available evidence calls for further research and development of extracorporeal liver support systems, with larger RCTs and optimization of patient selection, perfusion durability, and treatment protocols.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Ballas完成签到,获得积分10
刚刚
1秒前
1秒前
Seorina的应助被李一中采纳,获得10
2秒前
斯文败类的应助被荀万声采纳,获得10
2秒前
Wiki完成签到,获得积分10
2秒前
hu发布了新的文献求助10
2秒前
luoluoluoaaa123完成签到,获得积分10
4秒前
Horizon完成签到,获得积分10
4秒前
Qian发布了新的文献求助10
4秒前
xz发布了新的文献求助10
4秒前
溧谦发布了新的文献求助10
6秒前
赘婿的应助被kiwi采纳,获得10
7秒前
嘟嘟完成签到,获得积分10
8秒前
9秒前
草莓完成签到 ,获得积分10
9秒前
9秒前
liyuanyuan发布了新的文献求助10
9秒前
9秒前
10秒前
完美世界的应助被luxiaoyu采纳,获得10
10秒前
长安望星河完成签到,获得积分10
11秒前
慕青的应助被无私的画笔采纳,获得10
11秒前
顺心觅风完成签到,获得积分20
11秒前
luoluoluoaaa123关注了科研通微信公众号
11秒前
12秒前
多喝水发布了新的文献求助20
12秒前
14秒前
15秒前
葳蕤2完成签到 ,获得积分10
15秒前
16秒前
外向凡松完成签到,获得积分10
16秒前
16秒前
天天向上的应助被liyuanyuan采纳,获得10
17秒前
水弘的应助被张三说刑法采纳,获得30
18秒前
kennrei完成签到,获得积分10
18秒前
科研通AI6.4的应助被qrj采纳,获得10
19秒前
19秒前
荀万声发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183601
求助须知:如何正确求助?哪些是违规求助? 9572875
关于积分的说明 21827816
捐赠科研通 7780716
什么是DOI,文献DOI怎么找? 3434031
关于科研通互助平台的介绍 2558197
邀请新用户注册赠送积分活动 2480485